Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.24.1.u1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-in- Capital
Treasury Stock
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Beginning balance at Dec. 31, 2022 $ 57 $ 297,265 $ (7,625) $ 1,126 $ (180,751) $ 110,072
Beginning balance (in shares) at Dec. 31, 2022 54,693          
Increase (Decrease) in Stockholders' Equity            
Net income (loss)         1,051 1,051
Issuance of shares in connection with stock option exercise $ 1 1,523       1,524
Issuance of shares in connection with stock option exercise (in shares) 972          
Issuance of shares in connection with restricted stock units vesting $ 1         1
Issuance of shares in connection with restricted stock units vesting (in shares) 495          
Issuance of shares in connection with BOD fees   6       6
Issuance of shares in connection with BOD fees (in shares) 1          
Issuance of shares in connection with ESPP   221       221
Issuance of shares in connection with ESPP (in shares) 42          
Share-based compensation   4,170       4,170
Unrealized gain on deferred compensation trust assets       24   24
Ending balance at Apr. 01, 2023 $ 59 303,185 (7,625) 1,150 (179,700) 117,069
Ending balance (in shares) at Apr. 01, 2023 56,203          
Beginning balance at Dec. 30, 2023 $ 60 312,874 (11,912) 783 (188,974) 112,831
Beginning balance (in shares) at Dec. 30, 2023 56,303          
Increase (Decrease) in Stockholders' Equity            
Net income (loss)         (6,478) $ (6,478)
Issuance of shares in connection with stock option exercise (in shares)           0
Issuance of shares in connection with restricted stock units vesting $ 1 (323)       $ (322)
Issuance of shares in connection with restricted stock units vesting (in shares) 243          
Issuance of shares in connection with BOD fees   8       8
Issuance of shares in connection with ESPP   202       202
Issuance of shares in connection with ESPP (in shares) 75          
Officers and directors stock purchase plan (in shares) 3          
Share-based compensation   2,824       2,824
Unrealized gain on deferred compensation trust assets       87   87
Ending balance at Mar. 30, 2024 $ 61 $ 315,585 $ (11,912) $ 870 $ (195,452) $ 109,152
Ending balance (in shares) at Mar. 30, 2024 56,624